ArticleResearch square2025
Myelination selectively modulates BOLD signal in white matter.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
There is increasing recognition that blood oxygenation level dependent (BOLD) signals are detectable in white matter (WM) and reflect an important, heretofore overlooked functional activity in the brain, but their biophysical origins remain understudied and poorly understood. By integrating several disparate, multimodal data sets, we established the associations of resting state BOLD signals with key microstructural, hemodynamic and metabolic features in WM. In particular, we identified the roles of myelination and fiber type in modulating BOLD effects, and derived relationships between measurements of BOLD signal power and cerebral blood volume, flow, oxygen extraction and metabolic rate of oxygen consumption, which are predicted using a simple theory and then verified empirically. Our findings demonstrate that myelin selectively influences the fractional amplitude of low-frequency fluctuations (fALFF) in BOLD signals, and that differences in myelin content account for variations in their temporal spectra and hemodynamic response functions, but these in turn are qualitatively different in association versus projection fibers. Other determinants of BOLD in WM are further revealed by converging biological, genomic and neurochemical evidence, including measurements of neurite and mitochondrial densities. Moreover, analyses of images of the optic nerve from human subjects confirm that BOLD activations evoked by visual stimuli are preferentially localized to unmyelinated portions, with minimal responses in fully myelinated regions of the same nerve, suggesting a myelin-dependent requirement for BOLD effects in WM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.